Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The broad spectrum of lung diseases in primary antibody deficiencies.
Cinetto F, Scarpa R, Rattazzi M, Agostini C. Cinetto F, et al. Among authors: agostini c. Eur Respir Rev. 2018 Aug 29;27(149):180019. doi: 10.1183/16000617.0019-2018. Print 2018 Sep 30. Eur Respir Rev. 2018. PMID: 30158276 Free PMC article. Review.
Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies.
Milito C, Pulvirenti F, Cinetto F, Lougaris V, Soresina A, Pecoraro A, Vultaggio A, Carrabba M, Lassandro G, Plebani A, Spadaro G, Matucci A, Fabio G, Dellepiane RM, Martire B, Agostini C, Abeni D, Tabolli S, Quinti I. Milito C, et al. Among authors: agostini c. J Allergy Clin Immunol. 2019 Aug;144(2):584-593.e7. doi: 10.1016/j.jaci.2019.01.051. Epub 2019 Mar 22. J Allergy Clin Immunol. 2019. PMID: 30910492 Free article. Clinical Trial.
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.
Cinetto F, Neri R, Vianello F, Visentin A, Barilà G, Gianese S, Lanciarotta A, Milito C, Rattazzi M, Piazza F, Trentin L, Zambello R, Agostini C, Scarpa R. Cinetto F, et al. Among authors: agostini c. PLoS One. 2021 Mar 4;16(3):e0247717. doi: 10.1371/journal.pone.0247717. eCollection 2021. PLoS One. 2021. PMID: 33661940 Free PMC article.
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.
Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, Milito C, Trombetta AC, Visentini M, Martini H, Plebani A, Fiorilli M; IPINet Investigators. Quinti I, et al. Among authors: agostini c. J Clin Immunol. 2011 Jun;31(3):315-22. doi: 10.1007/s10875-011-9511-0. Epub 2011 Mar 2. J Clin Immunol. 2011. PMID: 21365217 Clinical Trial.
Rituximab in refractory sarcoidosis: a single centre experience.
Cinetto F, Compagno N, Scarpa R, Malipiero G, Agostini C. Cinetto F, et al. Among authors: agostini c. Clin Mol Allergy. 2015 Sep 1;13(1):19. doi: 10.1186/s12948-015-0025-9. eCollection 2015. Clin Mol Allergy. 2015. PMID: 26330764 Free PMC article.
Hyper-IgE in the allergy clinic--when is it primary immunodeficiency?
Ponsford MJ, Klocperk A, Pulvirenti F, Dalm VASH, Milota T, Cinetto F, Chovancova Z, Rial MJ, Sediva A, Litzman J, Agostini C, van Hagen M, Quinti I, Jolles S. Ponsford MJ, et al. Among authors: agostini c. Allergy. 2018 Nov;73(11):2122-2136. doi: 10.1111/all.13578. Epub 2018 Oct 2. Allergy. 2018. PMID: 30043993 Review.
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.
Pulvirenti F, Cinetto F, Pecoraro A, Carrabba M, Crescenzi L, Neri R, Bonanni L, Fabio G, Agostini C, Spadaro G, Tabolli S, Farrugia A, Quinti I, Milito C. Pulvirenti F, et al. Among authors: agostini c. J Clin Immunol. 2019 Feb;39(2):159-170. doi: 10.1007/s10875-019-0592-5. Epub 2019 Jan 15. J Clin Immunol. 2019. PMID: 30644015 Free PMC article.
485 results